UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India

Trials, 2022-01, Vol.23 (1), p.102-102, Article 102

2022

Volltextzugriff (PDF)

Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity

Blood, 2011-02, Vol.117 (5), p.1614-1621

2011

Volltextzugriff (PDF)

No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 study

Haematologica (Roma), 2024-07

2024

Volltextzugriff (PDF)

Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4755-4761

2010

Volltextzugriff (PDF)

Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia

Blood, 2011-06, Vol.117 (23), p.6247-6254

2011

Volltextzugriff (PDF)

Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017–2019

Cancer medicine (Malden, MA), 2023-04, Vol.12 (8), p.9293-9302

2023

Volltextzugriff (PDF)

Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.3499-3508

2023

Volltextzugriff (PDF)

How to write a research grant proposal

Indian journal of medical microbiology, 2024-05, Vol.49, p.100482, Article 100482

2024

Volltextzugriff (PDF)

Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton

Journal of extracellular vesicles, 2017-12, Vol.6 (1), p.1294339-n/a

2017

Volltextzugriff (PDF)

Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia

PloS one, 2017-06, Vol.12 (6), p.e0178606-e0178606

2017

Volltextzugriff (PDF)

Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial

PloS one, 2014-10, Vol.9 (10), p.e108107-e108107

2014

Volltextzugriff (PDF)

Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia

Haematologica (Roma), 2017-06, Vol.102 (6), p.1075-1084

2017

Volltextzugriff (PDF)

Complex Genomic Alterations and Gene Expression in Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21

Proceedings of the National Academy of Sciences - PNAS, 2006-05, Vol.103 (21), p.8167-8172

2006

Volltextzugriff (PDF)

Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata

Pediatric hematology oncology journal, 2022, Vol.7 (4), p.S56-S56

2022

Volltextzugriff (PDF)

Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region

JCO global oncology, 2023-02, Vol.9 (9), p.e2200295-e2200295

2023

Volltextzugriff (PDF)

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis

Health economics review, 2019-12, Vol.9 (40), p.1-13, Article 40

2019

Volltextzugriff (PDF)

Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia

The Lancet. Haematology, 2023-06, Vol.10 (6), p.e391-e393

2023

Volltextzugriff (PDF)

Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia

Pediatric hematology oncology journal, 2022, Vol.7 (4), p.S2-S2

2022

Volltextzugriff (PDF)

Reply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India—Implications for clinical outcomes in acute lymphoblastic leukaemia

Pediatric blood & cancer, 2022-02, Vol.69 (2), p.e29334-n/a

2022

Volltextzugriff (PDF)

Mixed-phenotypic acute leukemia series from tertiary care center

Indian journal of pathology & microbiology, 2017-01, Vol.60 (1), p.43-49

2017

Volltextzugriff (PDF)

Relapsed Acute Lymphoblastic Leukemia

Indian journal of pediatrics, 2024-02, Vol.91 (2), p.158-167

2024

Volltextzugriff (PDF)

Therapeutic drug monitoring informs asparaginase dose scheduling in the InPOG-ALL-15-01-ICiCLe-ALL-14 trial

Pediatric hematology oncology journal, 2017, Vol.2 (2), p.S2-S3

2017

Volltextzugriff (PDF)

PCR-based MRD testing for acute lymphoblastic leukaemia in India

Pediatric hematology oncology journal, 2017, Vol.2 (2), p.S14-S15

2017

Volltextzugriff (PDF)

Evolving strategies in the management of relapsed acute lymphoblastic leukaemia – TMCKidsALLR1

Pediatric hematology oncology journal, 2017, Vol.2 (2), p.S16-S16

2017

Volltextzugriff (PDF)

1 – 25 von 157

Suche als RSS-Feed

Aktive Filter

ThemaInfant

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(157)

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(66)
Humans
(61)
Child
(36)
Hematology
(36)
Oncology
(29)
Biological And Medical Sciences
(25)
Medical Sciences
(24)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(22)
Hematologic And Hematopoietic Diseases
(19)
Pediatrics
(19)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(17)
Male
(17)
Female
(16)
Leukemia
(15)
Technology
(13)
Acute Lymphoblastic Leukemia
(11)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(11)
Chemotherapy
(9)
Computer Science
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India

Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity

No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 study

Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005

Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia

Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017–2019

Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India

How to write a research grant proposal

Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton

Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia

Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial

Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia

Complex Genomic Alterations and Gene Expression in Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21

Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata

Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis

Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia

Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia

Reply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India—Implications for clinical outcomes in acute lymphoblastic leukaemia

Mixed-phenotypic acute leukemia series from tertiary care center

Relapsed Acute Lymphoblastic Leukemia

Therapeutic drug monitoring informs asparaginase dose scheduling in the InPOG-ALL-15-01-ICiCLe-ALL-14 trial

PCR-based MRD testing for acute lymphoblastic leukaemia in India

Evolving strategies in the management of relapsed acute lymphoblastic leukaemia – TMCKidsALLR1

Aktive Filter

Suchergebnisse filtern